WELLNEO SUGAR Co., Ltd.
2117・Prime Market・Foods
Business
Wellneo Sugar Co., Ltd. is the leading company in the refined sugar industry, formed in 2023 through the business integration of Nissin Sugar and Itochu Sugar. The group, comprising 10 subsidiaries and 12 affiliated companies, centers on the Sugar segment (manufacture and sale of refined sugar) while also operating the Food & Wellness segment (functional materials such as galacto-oligosaccharides and cyclic dextran, edible film, and fitness club operations). Its major customers are large food trading companies such as Itochu Shokuryo and Sumisho Foods, and it supplies sugar to both commercial and household markets while providing high-value-added materials to food and pharmaceutical manufacturers. Through the absorption-type merger with Toyo Sugar Refining (planned for October 2026), the company will establish a five-production-site network nationwide, further strengthening its competitive advantage in the refined sugar industry.
Business Model
The Sugar segment accounts for approximately 85.7% of revenue, with stable cash flow from the manufacturing and sale of refined sugar underpinning the business foundation. Meanwhile, the Food & Wellness segment sells functional materials such as galacto-oligosaccharides and cyclodextrin, as well as edible films, to food and pharmaceutical manufacturers, aiming to capture high value-added earnings. Securing stable sales channels through capital and business alliances with ITOCHU Corporation and Sumitomo Corporation, together with optimizing production and logistics costs through mergers, form the core of the earnings structure.
Company Strengths
Through the absorption-type merger with Toyo Sugar Refining (scheduled for October 2026), the company will establish a nationwide five-plant production network, driving optimization across procurement, production, logistics, and sales. In FY2026 (ending March 2026), the Sugar segment achieved revenue of ¥96,712 million and segment profit of ¥11,084 million, demonstrating the scale and earnings power of an industry-leading company.
Based on the three-party capital and business alliance agreement with Itochu Corporation and Sumitomo Corporation (concluded September 2022), the company has secured a stable sales channel via major trading companies, with sales to Itochu Shokuryo of ¥37,435 million (33.2% of revenue) and to Sumisho Foods of ¥11,659 million (10.3% of revenue). This represents a structural advantage that is difficult for competitors to replicate in the short term.
Full-scale production of the galacto-oligosaccharide product "Cup Oligo" began at the Mihama Bio Plant in April 2025, and production of CI (cyclodextran) is set to begin in April 2026. In FY2026 (ending March 2026), capital expenditure in the Food & Wellness segment reached ¥1,291 million, and construction of Toyo Sugar Refining's new functional materials plant (Sakura City, Chiba Prefecture; targeting full-scale operation from April 2027) is also underway.
ENVALITH's Perspective
Performance Trend
Revenue for FY2026 (ending March 2026) reached ¥112,904 million (up 16.3% year on year), and operating profit rose to ¥10,324 million (up 25.8% year on year), marking substantial growth in both revenue and profit. The main driver was the consolidation of Toyo Sugar Refining as a subsidiary from the end of the prior fiscal year, which lifted Sugar segment revenue to ¥96,712 million (up 15.4% year on year) and segment profit to ¥11,084 million (up 18.9% year on year). As external factors, overseas raw sugar market prices fell to the 13-cent range at one point during the period, and domestic refined sugar prices also declined by ¥8 in November; nevertheless, continued pass-through of selling prices and the consolidation effect from Toyo Sugar Refining pushed up profit. On the other hand, the recognition of an equity-method investment loss of ¥581 million weighed on profit before tax. For FY2027 (ending March 2027), the company forecasts revenue of ¥110,000 million and operating profit of ¥9,200 million, reversing to a decline in both revenue and profit, indicating that the pace of growth is entering a deceleration phase. Over the past five fiscal periods, operating profit expanded roughly 4.8-fold, from ¥2,164 million in FY2022 to ¥10,324 million in FY2026.
Growth Strategy
Aiming for a medium-term plan ROE of 9% and operating profit of ¥10,100 million through the two pillars of strengthening the Sugar business foundation and expanding Food & Wellness
The company will absorb Toyo Seito effective October 1, 2026, advancing optimization of procurement, production, logistics, and sales. Through the development and sophistication of a data utilization platform via core system integration, the company aims to improve operational efficiency and productivity, thereby expanding merger synergies and boosting business performance.
Full-scale production of galacto-oligosaccharide (Cup Oligo) began in April 2025, and production of CI (cyclodextran) also started at the same plant from April 2026. By expanding the supply capacity of CI, a unique material found nowhere else in the world, the company aims to expand earnings in the Food Science business.
Construction of a new functional materials plant is underway at Toyo Seito, which is scheduled to be absorbed into the company. Targeting full-scale operation from April 2027, the company will strengthen the supply system for functional food materials such as rutin and hesperidin, aiming to nurture the Food & Wellness segment into a second pillar of earnings after Sugar.
The company continues to strengthen sales of high-value-added products, led by "Kibi Zato" (raw cane sugar). It is pursuing profitability-focused management by combining price pass-through in response to rising costs with raw material procurement on favorable terms. In FY2026 (ending March 2026), sales volume of household-use products exceeded the previous period, confirming the effectiveness of these measures.
While proceeding with the consolidation of unprofitable stores, the company is working to improve advertising and promotional methods for the children's school business and expand its capacity to accept enrollees. Membership fee income has remained solid, but revenue continues to decline due to the impact of store closures in the previous period, making early recovery in performance a key challenge. Achieving the projected Food & Wellness segment profit of ¥600 million for FY2027 (ending March 2027) will serve as a litmus test.
Last updated: July 19, 2026